Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice
Loading...
Authors
Medical Center Staff
Issue Date
2005
Type
Language
en_US
Keywords
Alternative Title
Abstract
Description
Citation
Publisher
Stony Brook Medicine, Stony Brook University
License
Stony Brook University